Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Aug 2023
Historique:
revised: 12 06 2023
received: 04 01 2023
accepted: 20 06 2023
medline: 21 8 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Drug-coated balloons (DCBs) have been used in dialysis patients with arteriovenous fistula (AVF) stenosis, but whether DCBs have advantages over ordinary balloons is still controversial. A meta-analysis was designed to investigate the safety and efficacy of DCBs and common balloons (CBs) in the treatment of AVF stenosis. We searched the PubMed, EMBASE, and China National Knowledge Internet (CNKI) databases for randomized controlled trials that evaluated the comparison of DCB angioplasty versus CB angioplasty for AVF stenosis in dialysis patients and reported at least one outcome of interest. The results showed that the DCB group had a higher first-stage patency rate of the target lesion 6 months [odds ratio, OR = 2.31, 95% confidence interval, CI: (1.69, 3.15), p < .01] and 12 months [OR = 2.09, 95% CI: (1.50, 2.91), p < .01] after surgery. There was no statistically significant difference in all-cause mortality between the two groups at 6 months [OR = 0.85, 95% CI: (0.47, 1.52), p = .58] and 12 months [OR = 0.99, 95% CI: (0.60, 1.64), p = .97]. Compared with CB, DCBs as a new endovascular treatment for AVF stenosis have a higher primary patency rate of target lesions and can delay the occurrence of restenosis. There is no evidence that DCB can increase the mortality of patients.

Identifiants

pubmed: 37417371
doi: 10.1002/clc.24078
pmc: PMC10436783
doi:

Substances chimiques

Coated Materials, Biocompatible 0
Paclitaxel P88XT4IS4D

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

877-885

Informations de copyright

© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Références

Front Neuroendocrinol. 2019 Jan;52:22-28
pubmed: 29908879
Circulation. 2004 Aug 17;110(7):810-4
pubmed: 15302790
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
J Am Coll Cardiol. 2019 May 28;73(20):2550-2563
pubmed: 30690141
J Am Heart Assoc. 2019 May 21;8(10):e012315
pubmed: 31094268
Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164
pubmed: 32778223
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2515-2524
pubmed: 31575518
Circulation. 2009 Jun 30;119(25):3198-206
pubmed: 19528338
Nephrol Dial Transplant. 2011 Aug;26(8):2604-10
pubmed: 21245131
J Vasc Interv Radiol. 2018 Apr;29(4):470-475.e3
pubmed: 29471988
J Vasc Surg. 2020 Jun;71(6):1994-2003
pubmed: 31611105
Cardiovasc Intervent Radiol. 2020 Mar;43(3):382-390
pubmed: 31722055
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1215-1224
pubmed: 30042225
J Int Med Res. 2022 Mar;50(3):3000605221081662
pubmed: 35354342
Front Pharmacol. 2022 May 17;13:823530
pubmed: 35656294
N Engl J Med. 2010 Feb 11;362(6):494-503
pubmed: 20147715
Radiology. 2018 Oct;289(1):238-247
pubmed: 30040057
J Vasc Interv Radiol. 2014 Apr;25(4):535-41
pubmed: 24529550
Diagn Interv Radiol. 2015 Mar-Apr;21(2):160-6
pubmed: 25698092
Am J Kidney Dis. 2021 Jul;78(1):19-27.e1
pubmed: 33418016
Scand J Surg. 2019 Mar;108(1):61-66
pubmed: 30182815
J Vasc Interv Radiol. 2017 Jun;28(6):811-817
pubmed: 28434662
Clin Cardiol. 2023 Aug;46(8):877-885
pubmed: 37417371
J Vasc Access. 2019 May;20(3):260-269
pubmed: 30227772
N Engl J Med. 2020 Aug 20;383(8):733-742
pubmed: 32813949
Sci Rep. 2016 Feb 23;6:22197
pubmed: 26902330
J Am Heart Assoc. 2018 Dec 18;7(24):e011245
pubmed: 30561254
PLoS One. 2020 Apr 14;15(4):e0231463
pubmed: 32287283
Am J Kidney Dis. 2017 Jan;69(1):147-151
pubmed: 28084215
Indian J Nephrol. 2022 May-Jun;32(3):233-239
pubmed: 35814313
J Vasc Interv Radiol. 2015 Mar;26(3):348-54
pubmed: 25542635

Auteurs

Yong Zhang (Y)

Department of Nephrology, Jianli People's Hospital, Jingzhou, China.

Fan-Li Yuan (FL)

Department of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China.

Xiang-Yang Hu (XY)

Department of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.

Qi-Bing Wang (QB)

Department of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.

Zhen-Wu Zou (ZW)

Department of General Practice, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.

Zhen-Guo Li (ZG)

Department of Pediatrics, Jianli People's Hospital, Jingzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH